In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 05 (10) , 677-679
- https://doi.org/10.1023/a:1015939307478
Abstract
The influence of lipid vehicles on the intestinal absorption of Ciclosporin was studied in vivo. The model takes into account the effect of the intestinal lipid digestion on the absorption after intraduodenal administration of [3H]Ciclosporin in olive oil or middle-chain triglyceride (MCT) to the bile duct-cannulated rat. Digested vehicles significantly promoted the absorption compared to nondigested vehicles. In the nondigested state, olive oil was a significantly better vehicle than MCT, whereas the difference between both lipids was only a trend in the digested state. Further studies with variants of this in vivo model should determine the influence of abnormalities of fat digestion and absorption on the pharmacokinetics and pharmacodynamics of a drug with a low therapeutical index.This publication has 11 references indexed in Scilit:
- In Vitro Model for Ciclosporin Intestinal Absorption in Lipid VehiclesPharmaceutical Research, 1988
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986
- Extraction Ratio of Cyclosporine in a Liver Transplant Patient with Organ RejectionJournal of Pharmaceutical Sciences, 1985
- The effect of different oils on the absorption of probucol in the ratJournal of Pharmacy and Pharmacology, 1984
- Lipid Digestion and AbsorptionAnnual Review of Physiology, 1983
- Intestinal lymphatic absorption of cyclosporin a following oral administration in an olive oil solution in ratsBiopharmaceutics & Drug Disposition, 1983
- The effect of oils on the lymphatic absorption of DDTJournal of Pharmacy and Pharmacology, 1982
- Rat lingual lipase. Characteristics of enzyme activity.Journal of Biological Chemistry, 1979
- Bioavailability of Micronized Griseofulvin from Corn Oil‐in‐Water Emulsion, Aqueous Suspension, and Commercial Tablet Dosage Forms in HumansJournal of Pharmaceutical Sciences, 1975
- Failure of bile acids to control hepatic cholesterogenesis: evidence for endogenous cholesterol feedbackJournal of Clinical Investigation, 1969